PSMA+ mCRPC

PSMA+ mCRPC

Integrating Recent FDA Approvals for Metastatic Castration-Resistant Prostate Cancer Into Clinical Practice

clinical topic updates
By Neeraj Agarwal, MD, FASCO

PSMA+ mCRPC

Balancing Precision in Patient Selection With Equitable Access to Therapy

patient care perspectives
By Neeraj Agarwal, MD, FASCO

PSMA+ mCRPC

PARP Inhibitor Benefit in Patients With Metastatic Castration-Resistant Prostate Cancer

clinical topic updates
By Neeraj Agarwal, MD, FASCO

PSMA+ mCRPC

The Evolving Role of Prostate-Specific Membrane Antigen Positron Emission Tomography Across the Prostate Cancer Disease Continuum

patient care perspectives
By Neeraj Agarwal, MD, FASCO

PSMA+ mCRPC

Second Taxane for Progression After Triplet Therapy: Treatment Considerations

clinical topic updates
By William K. Oh, MD